Huvepharma marked its 25th anniversary with a high-profile symposium in Madrid on Sept. 23–25, 2025, convening more than 400 guests from 61 countries to debate “The Sustainable Future of Livestock Production.” The program opened with a rooftop reception on Gran Via and concluded with a gala at the Plaza de Toros de Las Ventas, framing two days of content at the Pablo VI Conference Hall that blended geopolitics, market signals, and on-farm innovation.
Why it matters for the business side
The agenda underscored where margins will be made (or lost) in the next cycle: supply-chain resilience, feed efficiency, disease risk management, and consumer-driven product design. In his video address, Kiril Domuschiev traced Huvepharma’s evolution from API roots to an integrated animal-health portfolio across the US and Europe. The strategic throughline: science-led manufacturing plus proximity to customers to reduce uncertainty in a world of shifting trade routes and regulations.
Eddy Piron, VP Sales & Marketing, set the commercial tone by thanking industry bodies (including FEFAC and Animalhealth Europe) and mapping Huvepharma’s focus: a livestock-only model (poultry, cattle, swine) with a broad toolbox—vaccines, enzymes, coccidiostats, hygiene and veterinary medicines—delivered with technical service.
The company’s thesis is straightforward: performance and biosecurity are profit levers, and integrated supply is a trust signal when logistics and policy are volatile.
Signals for investors and producers
From science to margin: where the symposium drilled down
Satellite sessions targeted poultry and ruminants with a practical tilt:
On the plenary stage, Arlin Wasserman unpacked profitable sustainability—how claims, formats, and pricing power must connect. Christophe Pelletier pushed beyond “good intentions” to execution along the farmer-to-consumer chain, while Marcos Jank grounded the discussion in sector economics and trade dynamics.
Culture and narrative still move markets
Storytelling met science when Dr. Mark Lyons and Susanna Elliott (Alltech) screened World Without Cows, provoking a data-rich discussion on cattle’s cultural, nutritional, and climate roles. For brand owners and integrators, the message was clear: license to operate now depends on credible, evidence-based narratives as much as on technical KPIs.
Huvepharma’s 25th year platformed a coherent operating philosophy:
For producers, the practical translation is margin protection: fewer disease shocks, better feed utilization, and steadier throughput. For partners and policymakers, the Madrid conversations reinforced that the sector’s sustainability targets and its business outcomes are converging—the more predictable biology becomes, the more bankable livestock systems will be.
All rights reserved to The Animal Economics © Copyright 2026 | Web design & implementation: PAQ Consultancy
This website uses cookies. For details, please see our privacy policy. By clicking on the relevant button or any other element of the page, you consent to the use of cookies.